BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36281404)

  • 1. High expression COL10A1 promotes breast cancer progression and predicts poor prognosis.
    Zhou W; Li Y; Gu D; Xu J; Wang R; Wang H; Liu C
    Heliyon; 2022 Oct; 8(10):e11083. PubMed ID: 36281404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
    Zhang M; Chen H; Wang M; Bai F; Wu K
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of miR-505 promotes cell proliferation, migration and invasion, and predicts poor prognosis in breast cancer.
    Wang J; Liu H; Li M
    Oncol Lett; 2019 Jul; 18(1):247-254. PubMed ID: 31289494
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Wang C; Wang J; Chen S; Li K; Wan S; Yang L
    Curr Cancer Drug Targets; 2024; 24(3):340-353. PubMed ID: 37592784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen Type X Alpha 1 (COL10A1) Contributes to Cell Proliferation, Migration, and Invasion by Targeting Prolyl 4-Hydroxylase Beta Polypeptide (P4HB) in Breast Cancer.
    Yang W; Wu X; Zhou F
    Med Sci Monit; 2021 Feb; 27():e928919. PubMed ID: 33637669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of COL10A1 is associated with poor prognosis in colorectal cancer.
    Huang H; Li T; Ye G; Zhao L; Zhang Z; Mo D; Wang Y; Zhang C; Deng H; Li G; Liu H
    Onco Targets Ther; 2018; 11():1571-1581. PubMed ID: 29593423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic significance in gastric cancer based on bioinformatics.
    Chen S; Wei Y; Liu H; Gong Y; Zhou Y; Yang H; Tang L
    Bioengineered; 2021 Dec; 12(1):127-137. PubMed ID: 33371777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Expression of COL10A1 Is an Independent Predictive Poor Prognostic Biomarker and Associated with Immune Infiltration in Advanced Gastric Cancer Microenvironment.
    Shen N; Zhu S; Zhang Z; Yong X
    J Oncol; 2022; 2022():1463316. PubMed ID: 36276283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics-Based Analysis: Noncoding RNA-Mediated COL10A1 Is Associated with Poor Prognosis and Immune Cell Infiltration in Pancreatic Cancer.
    Liu Q; Zhao H; Guo Y; Zhang K; Shang F; Liu T
    J Healthc Eng; 2022; 2022():7904982. PubMed ID: 36105715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
    Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
    Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis.
    Luo Y; He Z; Liu W; Zhou F; Liu T; Wang G
    Oxid Med Cell Longev; 2022; 2022():3369858. PubMed ID: 35103094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UBE2T promotes proliferation, invasion and glycolysis of breast cancer cells by regualting the PI3K/AKT signaling pathway.
    Qiao L; Dong C; Ma B
    J Recept Signal Transduct Res; 2022 Apr; 42(2):151-159. PubMed ID: 33435787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A panel of 8-lncRNA predicts prognosis of breast cancer patients and migration of breast cancer cells.
    Zhu L; Cui K; Weng L; Yu P; Du Y; Zhang T; Liu H; Li B; Ma W
    PLoS One; 2021; 16(6):e0249174. PubMed ID: 34086679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancer.
    Xu S; Liu D; Qin Z; Liang Z; Xie H; Yi B; Wang K; Lin G; Liu R; Yang K; Xu Y; Zhang H
    Aging (Albany NY); 2023 Dec; 15(24):15134-15160. PubMed ID: 38147021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROC1 promotes the malignant progression of bladder cancer by regulating p-IκBα/NF-κB signaling.
    Wu Q; Zhou X; Li P; Ding M; You S; Xu Z; Ye J; Chen X; Tan M; Wang J; Wang W; Qiu J
    J Exp Clin Cancer Res; 2021 May; 40(1):158. PubMed ID: 33962660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosome-derived ANXA9 functions as an oncogene in breast cancer.
    Lu C; Zhan Y; Jiang Y; Liao J; Qiu Z
    J Pathol Clin Res; 2023 Sep; 9(5):378-390. PubMed ID: 37294149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
    Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
    Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MST1 inhibits the progression of breast cancer by regulating the Hippo signaling pathway and may serve as a prognostic biomarker.
    Jin X; Zhu L; Xiao S; Cui Z; Tang J; Yu J; Xie M
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated Collagen COL10A1 Remodels the Extracellular Matrix and Promotes Malignant Progression in Lung Adenocarcinoma.
    Liang Y; Xia W; Zhang T; Chen B; Wang H; Song X; Zhang Z; Xu L; Dong G; Jiang F
    Front Oncol; 2020; 10():573534. PubMed ID: 33324550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COL10A1-DDR2 axis promotes the progression of pancreatic cancer by regulating MEK/ERK signal transduction.
    Wen Z; Sun J; Luo J; Fu Y; Qiu Y; Li Y; Xu Y; Wu H; Zhang Q
    Front Oncol; 2022; 12():1049345. PubMed ID: 36530986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.